MedTrace Logo

Serum BDNF Role as a Biomarker for Stroke Rehabilitation

NCT03164798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-03-18

No results posted yet for this study

Summary

This study aims to develop the quantitative biomarker to establish the individualized strategy in stroke rehabilitation. Brain-derived neurotrophic factor (BDNF) acts on certain neurons of the central nervous system (CNS) helping to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses. BDNF in CNS can be assessed by analysing serum BDNF. The final objective of this study is to demonstrate a role of biomarker of BDNF in stroke rehabilitation to establish the individualized strategy.

Conditions

  • Stroke
  • Biomarker
  • Rehabilitation
  • BDNF

Interventions

PROCEDURE

Conventional inpatient rehabilitation

comprehensive inpatient rehabilitation for 2 weeks

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Won Hyuk Chang, MD, PhD · Samsung Medical Center

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2019-08-31
Completion
2019-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03164798 on ClinicalTrials.gov